„There’s a widespread belief that marijuana is ‘natural’ and therefore harmless,“ Corey Gamberg, a mental health and addiction specialist who serves as executive director of the Rockland Recovery Center and Massachusetts Center for Addiction, told Fox News Digital. „Without this coordination, there’s a risk employees receive medication without addressing the broader behavioral health needs that drive alcohol-related absenteeism, healthcare costs and safety concerns.“ While the early results of these studies are promising, Harrison emphasized that GLP-1 drugs should be part of a comprehensive care plan.

NACo Public Health Leadership Academy Application Information Session

Adolescent cannabis use surges in Oklahoma, raising public health concerns amid rising THC potency and permissive regulations. Kaplan agreed, noting that more research on the effects of semaglutide on alcohol use is needed. “This class of drugs have been around for 20+ years so we do know the most common side effects are GI in nature (nausea, vomiting, constipation and diarrhea),” Kaplan said.

Meta, YouTube on trial over teen addiction, compared to big tobacco era

Several countries (Australia, Canada, Italy, the United Kingdom of Great Britain and Northern Ireland and Ukraine) have introduced naloxone as over-the-counter medication and have also started proactive dissemination in communities. Adial Pharmaceuticals is focused on developing therapies for the treatment and prevention of addiction and related disorders. As part of its efforts to raise awareness of and combat underage drinking, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) has launched NIAAA for Middle School.

More on Substance Abuse and Addiction

The HIPAA Notice of Privacy Practices is not required to include information concerning reproductive health. Provisions of the HIPAA Privacy Rule to Support Reproductive Health Care Privacy requiring such modifications was vacated by a decision of the U.S. Marc Potenza, PhD, MD, explores the impact of online social activity on ADHD symptoms in adolescents, revealing significant gender differences in brain development and attention. The FDA has granted a Type C Meeting to Nutriband for their Aversa fentanyl patch, which aims to revolutionize pain management with its innovative abuse-deterrent technology.

• Becoming a member offers access to a network of professionals, fostering valuable connections and collaboration opportunities.
• As the ongoing behavioral health crisis is addressed in counties throughout the country, NACo remains dedicated to advocating for the passage of key county priorities that support behavioral health systems and provide pathways to treatment for individuals with mental illness and SUD.
• Dental practices may receive these records as part of a patient’s health history or through coordination of care with other providers.

What is Adial Pharmaceuticals focused on?

NIAAA for Middle School is an online resource that helps parents, caregivers, and teachers introduce and reinforce key messages about peer pressure and skills for resisting it, as well as about other important topics related to underage drinking. In the current study, the researchers demonstrated that semaglutide reduced binge-like alcohol drinking in both male and female mice, and that the effect was dose-dependent (i.e., greater amounts of semaglutide led to greater reductions in binge alcohol intake). The researchers also tested semaglutide in rats that were made dependent on alcohol through long-term exposure to alcohol vapor. They found that semaglutide reduced alcohol intake in this animal model, again with no sex differences.

• Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders.
• NIAAA for Middle School is an online resource that helps parents, caregivers, and teachers introduce and reinforce key messages about peer pressure and skills for resisting it, as well as about other important topics related to underage drinking.
• We’re excited to introduce you to a refreshed, easier‑to‑use GDA experience designed to better support your membership and your practice.
• As federal agencies including the FDA and NIDA are now formally directed to collaborate on defining and implementing these alternative endpoints, the measures are expected to strengthen the regulatory framework for innovative therapies such as AD04.
• At a time when our elected lawmakers do not seem to agree on very much, there is broad bipartisan and bicameral recognition of the need to address this issue.

Business services

There is a lot of work ahead of us as we commit to rolling back the epidemic of substance use disorders that afflict so many Americans, both inside and outside the health care field. The challenge represents a real opportunity for all sectors of our society to come together in partnership to advance health for everyone. Most recently, the AHA released a toolkit to help clinicians improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for Disease Control and Prevention and in partnership with clinical teams from Oregon Health & Science University, Trinity Health of New England and the University of Kentucky, the toolkit offers practical strategies across inpatient, primary care and pharmacy settings.

Fox News’ Mark Meredith joins ‘America’s Newsroom’ to break down the growing ‘California Sober’ trend among Gen Z, how increased cannabis use may be driving down alcohol consumption and the possible risks, including dependency. This disparity is visible in health statistics, where men account for the majority of drug-related deaths and the highest rates of illness and disability across various regions. Though patterns of substance use are dynamic, men generally initiate use at an earlier age, a crucial factor in the development of long-term dependence. So, any HIPAA covered entities that substance use disorder create, maintain, receive or transmit any SUD treatment information should review and make appropriate updates to their HIPAA Notice of Privacy Practices (NPP) by February 16, 2026. The updated sample Notice of Privacy Practices is intended to help dental practices meet their legal obligations while clearly communicating patients’ privacy rights.